STOCK TITAN

Medtronic Plc - MDT STOCK NEWS

Welcome to our dedicated news page for Medtronic Plc (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medtronic Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medtronic Plc's position in the market.

Rhea-AI Summary
Medtronic plc (NYSE:MDT) approved a cash dividend of $0.69 per ordinary share for the third quarter of fiscal year 2024. The company has consistently increased its annual dividend payment for the past 46 years and is a constituent of the S&P 500 Dividend Aristocrats index. The dividend is payable on January 12, 2024, to shareholders of record at the close of business on December 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
dividends earnings
-
Rhea-AI Summary
Medtronic (MDT) focuses on reducing health disparities in a meaningful, sustainable, and scalable way
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary
Medtronic LABS (MDT) makes its digital health platform SPICE open source, accelerating access to healthcare in underserved communities. Since 2013, the nonprofit has enrolled over 217,000 people in one million patients healthcare and trained over 8,000 community health workers in multiple countries. SPICE is a digital health platform embedded within health systems and government digital ecosystems, screening patients for various conditions and connecting them to care. Becoming open source allowed LABS to receive the designation as a Digital Public Good by a United Nations-endorsed initiative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
none
Rhea-AI Summary
Medtronic plc (MDT) reported a 5.3% revenue growth in Q2 of fiscal year 2024, reaching $8.0 billion. The company raised its fiscal year guidance for organic revenue growth and EPS. They received U.S. FDA approval for innovative products and witnessed strong performance across multiple businesses and geographies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.6%
Tags
-
Rhea-AI Summary
Medtronic plc (NYSE: MDT) - FDA Approves Symplicity Blood Pressure Procedure, Offering Patients a New Adjunct Approach to Lowering Blood Pressure - Medtronic's Symplicity blood pressure procedure, also known as the Symplicity Spyral renal denervation (RDN) system, has been approved by the FDA for the treatment of hypertension. This approval marks a significant milestone in the treatment of high blood pressure, providing a minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys to help manage blood pressure. The procedure has been shown to be safe and effective, offering significant blood pressure reductions for patients. Medtronic will immediately begin commercialization of the Symplicity blood pressure procedure, aiming to fulfill the significant unmet need in hypertension care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Medtronic - Survey Reveals Optimism for AI in Healthcare
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
AI
Rhea-AI Summary
Medtronic: Survey Reveals Optimism for AI in Healthcare
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.98%
Tags
AI
-
News
Rhea-AI Summary
Medtronic (MDT) collaborates with the Ministry of Health, Royal Government of Bhutan, ADA, The United Nations Technology Bank, MED-EL, and others to revolutionize pediatric ear and hearing care in Bhutan. The World Health Organization (WHO) reports 32 million children worldwide affected by hearing loss, with 60% preventable through early detection and public health measures. In Bhutan, 2.2% of the population has some form of hearing disorder.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
-
Rhea-AI Summary
Medtronic plc (NYSE: MDT) will report financial results for its second quarter of fiscal year 2024 on November 21, 2023. The news release will include summary financial information for the company's second quarter, which ended on October 27, 2023. A video webcast to discuss the results will be hosted at 7:00 a.m. CST on November 21, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
Rhea-AI Summary
Medtronic, a global medical device company, is committed to reducing waste generated from the packaging of medical devices. By the end of 2025, they aim to reduce packaging waste on select product lines by 25%, which is projected to lead to a reduction of approximately 130 tons of packaging material.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
none
Medtronic Plc

NYSE:MDT

MDT Rankings

MDT Stock Data

106.40B
1.33B
0.11%
85.18%
0.94%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Minneapolis

About MDT

Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.